Mark J. Vignola
Chief Financial Officer, Applied Therapeutics, Inc.
Companies
- Korsana Biosciences, Inc.Chief financial officer Sep 10, 2026 to now1
- Terns Pharmaceuticals, Inc.Chief financial officer Feb 4, 2021 to Feb 25, 20252
- Applied Therapeutics, Inc.Chief financial officer May 13, 2019 to May 15, 20193
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Terns Pharmaceuticals, Inc.74,752 shares4Jan 6, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 6, 2025Sold 9,059 shares at $5.80 of Terns Pharmaceuticals, Inc.4
- Jan 2, 2025Sold 8,129 shares at $5.72 of Terns Pharmaceuticals, Inc.4
- Sep 10, 2024Sold 10,000 shares at $11.00 of Terns Pharmaceuticals, Inc.5
- Sep 10, 2024Exercised options 10,000 shares at $5.36 of Terns Pharmaceuticals, Inc.5
- May 31, 2024Bought 4,791 shares at $4.44 of Terns Pharmaceuticals, Inc.6
- Jan 23, 2024Granted 68,750 shares of Terns Pharmaceuticals, Inc.7
- Nov 30, 2023Bought 743 shares at $3.78 of Terns Pharmaceuticals, Inc.8
- May 31, 2023Bought 9,997 shares at $1.41 of Terns Pharmaceuticals, Inc.9
- Nov 30, 2022Bought 3 shares at $1.41 of Terns Pharmaceuticals, Inc.10
- May 31, 2022Bought 7,656 shares at $1.47 of Terns Pharmaceuticals, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Sep 12, 2024
- 6SEC EDGARForm 4 filed Jun 4, 2024
- 7SEC EDGARForm 4 filed Jan 25, 2024
- 8SEC EDGARForm 4 filed Dec 4, 2023
- 9SEC EDGARForm 4 filed Jun 2, 2023
- 10SEC EDGARForm 4 filed Feb 3, 2023
- 11SEC EDGARForm 4 filed Jun 8, 2022